Alexandra Heaton
Director, Operations / NeuroScientific Biopharmaceuticals
Dr Alexandra Heaton holds a PhD in Neuroscience from the University of Western Australia. Her research work focused on anti-oxidative, anti-inflammatory and anti-apoptotic effects of dietary supplementation in the brain in addition to enhancing neuroplasticity, synaptogenesis and neural signalling.
Dr Heaton joined Neuroscientific Biopharmaceuticals in February 2019 and worked in investor relations and corporate development before being appointed director of operations in September 2020. Prior to that, she was the US client engagement with Linear Clinical Research with a focus on attracting partnerships with US biotechnology and pharmaceutical companies.
